The company's products eliminate the need for glue, collagen, and suturing, reducing clinical reactions and residual material in patients. Their technology expedites arterial closure through hemostasis, benefiting cardiologists, radiologists, cath-labs, and patients in diagnostic and therapeutic markets. Founded in 2004, CardioDex is a cardiovascular genomic diagnostics company based in Redwood City, CA.